StockData
Evogene Ltd. logo

Evogene Ltd. (EVGN) stock

EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30
$0.35+0.01 (+2.91%)

Close on Nov 18, 2026Market cap $3.05MP/E 0.3Yield –

Evogene free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -$13.64M. The highest annual figure on record is -$12.50M in fiscal 2016.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$13.64M–
FY2024Dec 31, 2024-$20.33M–
FY2023Dec 31, 2023-$22.15M–
FY2022Dec 31, 2022-$24.85M–
FY2021Dec 31, 2021-$25.56M–
FY2020Dec 31, 2020-$20.20M–
FY2019Dec 31, 2019-$18.57M–
FY2018Dec 31, 2018-$15.54M–
FY2017Dec 31, 2017-$16.52M–
FY2016Dec 31, 2016-$12.50M–
FY2015Dec 31, 2015-$14.41M–

More Evogene figures

See a number that looks wrong?